{Reference Type}: Journal Article
{Title}: Diagnostic Value of Imaging and Serological Biomarkers in Pulmonary Sarcoidosis.
{Author}: Li Y;Xu G;
{Journal}: Adv Respir Med
{Volume}: 92
{Issue}: 3
{Year}: 2024 Apr 28
暂无{DOI}: 10.3390/arm92030020
{Abstract}: Sarcoidosis is a multisystem granulomatous disease of an unknown aetiology. It can exist in many organs. Pulmonary and intrathoracic lymph nodes are most commonly involved. Lung sarcoidosis is uncommon in Asia. However, due to the large population of our country and the development of bronchoscopy, percutaneous lung puncture, and other medical technologies, the number of pulmonary sarcoidosis patients is on the rise. Pulmonary sarcoidosis patients have no obvious symptoms in the early stage, and the clinical manifestations in the later stage may vary from person to person. Eventually, the disease progresses to life-threatening pulmonary fibrosis. Therefore, patients with pulmonary sarcoidosis should receive a timely diagnosis. In recent years, the imaging features and serologic biomarkers of pulmonary sarcoidosis have been continuously studied. The diagnostic value of imaging and serologic biomarkers for pulmonary sarcoidosis is summarized below.